Company Monitoring Page for Oyster-Point-Pharma

latest headlines for company on cafepharma

Viatris to buy two eye drug developers in deals worth up to $750M
BioPharma Dive
Mon, 11/7/22 - 05:29 pm
Tags:
Viatris, M&A, Oyster Point Pharma, Famy Life Sciences, eye health
Oyster Point plows ahead with 50 layoffs to focus on approved eye drug
Fierce Biotech
Fri, 08/12/22 - 10:26 am
Tags:
Oyster Point Pharma, layoffs, dry eye disease
Oyster Point Laying Off 50 with Focus on Dry Eye Drug Launch
BioSpace
Thu, 06/30/22 - 11:05 am
Tags:
Oyster Point Pharma, layoffs, dry eye disease, Tyrvaya
Why Pfizer Isn't the Big Winner With a Newly Approved Version of Chantix
Motley Fool
Sat, 10/30/21 - 10:50 pm
Tags:
Pfizer, Chantix, dry eye disease, Oyster Point Pharma
FDA OKs an inhaled version of smoking cessation drug Chantix — for a common eye disease
Endpoints
Mon, 10/18/21 - 11:57 am
Tags:
Oyster Point Pharma, Tyrvaya, FDA, dry eye disease, Chantix
Oyster Point Pharma Inks Deal with Ji Xing for Dry Eye Disease Therapies
BioSpace
Sun, 08/8/21 - 12:00 am
Tags:
Oyster Point Pharma, Ji Xing Pharmaceuticals, OC-01, OC-02, dry eye disease, China
Five Collaborations Unlocking Faster Drug Development this Week
BioSpace
Thu, 06/10/21 - 11:12 am
Tags:
drug development, MannKind, Thirona Bio, pulmonary fibrosis, Oyster Point Pharma, Adaptive Phage Therapeutics, ophthalmic, Takeda, Codexis, ALX Oncology, Eli Lilly, clinical trials, BeiGene, Shoreline Biosciences, oncology
Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray
Endpoints
Mon, 05/11/20 - 10:36 am
Tags:
Oyster Point Pharma, dry eye disease, OC-01, Allergan, Restasis, Shire, Xiidra
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Tags:
Adamis Pharmaceuticals, Redhill Biopharma, Amag Pharmaceuticals, Arqule, Agile Therapeutics, Agios Pharmaceuticals, Deciphera, Mirati Therapeutics, Sutro BioPharma, Merck, Pfizer, Amgen, EXACT Sciences, Bristol-Myers Squibb, Celgene, Oyster Point Pharma
Oyster Point Pharma Files for $85 Million IPO
CP Wire
Mon, 10/7/19 - 10:57 am
Tags:
Oyster Point Pharma, dry eye disease, OC-01, IPOs
Mon, 10/7/19 - 10:09 am
Tags:
Oyster Point Pharma, dry eye disease, OC-01, IPOs

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.